Sedana Medical is a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient’s life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical product Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care.

Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, the Nordic, and Spain. In other parts of Europe as well as in Asia, Australia, Canada, and South- and Central America, the company works with external distributors.

Sedana Medical was founded in 2005, is listed on Nasdaq Stockholm and is headquartered in Stockholm, Sweden.

Sedana Medical’s products are developed and manufactured in accordance with quality-controlled processes. The company has a quality management system that fulfils the requirements of ISO 13485 (design and manufacturing of medical devices) and holds MDSAP certificates for Canada and Japan.